<DOC>
	<DOC>NCT01108393</DOC>
	<brief_summary>The study will evaluate the efficacy of agomelatine compared to placebo on the reduction of Obsessive and Compulsive symptoms after 16 weeks of treatment.</brief_summary>
	<brief_title>Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>S 20098</mesh_term>
	<criteria>Obsessive Compulsive Disorder (OCD) according to Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSMIVTR), YBOCS total score â‰¥ 20, duration of OCD symptoms of at least one year. Bipolar disorder, Schizophrenic or Psychotic Disorder Severe or uncontrolled organic diseases Neurological disorder Women of childbearing potential who are not using effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Obsessive Compulsive Disorder</keyword>
	<keyword>Agomelatine</keyword>
</DOC>